PT - JOURNAL ARTICLE AU - J. Robert Lane AU - Ben Powney AU - Alan Wise AU - Stephen Rees AU - Graeme Milligan TI - G Protein Coupling and Ligand Selectivity of the D<sub>2L</sub> and D<sub>3</sub> Dopamine Receptors AID - 10.1124/jpet.107.134296 DP - 2008 Apr 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 319--330 VI - 325 IP - 1 4099 - http://jpet.aspetjournals.org/content/325/1/319.short 4100 - http://jpet.aspetjournals.org/content/325/1/319.full SO - J Pharmacol Exp Ther2008 Apr 01; 325 AB - The human dopamine D2L receptor couples promiscuously to multiple members of the Gαi/o subfamily. Despite the high homology of the D2L and D3 receptors, the G protein coupling specificity of the human D3 receptor is less clearly characterized. The primary aim of this study, then, was the parallel characterization of the G protein coupling specificity of the D2L and D3 receptors. By using both receptor-G protein fusion proteins and stable cell lines in which pertussis toxin-resistant mutants of individual Gαi-family G proteins were expressed in an inducible fashion, we demonstrated highly selective coupling of the D3 receptor to Gαo1. Furthermore, by using the fusion proteins to ensure identical stoichiometry of receptor to G protein for each pairing, a range of ligands displayed higher potency and, for partial agonists, higher efficacy at the D3 receptor when coupled to Gαo1 compared with the D2L receptor. The second aim of this study was to investigate the molecular basis of the above differential G protein coupling specificity. The importance of a 12-amino acid sequence from the C-terminal end of the third intracellular loop of the D2L receptor in providing promiscuity in G protein coupling was demonstrated using a chimeric D3/D2 receptor in which the equivalent region of the D3 receptor was exchanged for this sequence. This chimera displayed D3-like affinity for [3H]spiperone and potency for agonists but gained D2-like ability to couple to each of Gαi1–3 as well as Gαo1. The American Society for Pharmacology and Experimental Therapeutics